Chapman CG - Search Results

1

The neuroprotective agent sipatrigine (BW619C89) potently inhibits the human tandem pore-domain K(+) channels TREK-1 and TRAAK.

Meadows HJ, Chapman CG, Duckworth DM, Kelsell RE, Murdock PR, Nasir S, Rennie G, Randall AD. Meadows HJ, et al. Among authors: chapman cg. Brain Res. 2001 Feb 16;892(1):94-101. doi: 10.1016/s0006-8993(00)03239-x. Brain Res. 2001. PMID: 11172753

2

Cloning, localisation and functional expression of the human orthologue of the TREK-1 potassium channel.

Meadows HJ, Benham CD, Cairns W, Gloger I, Jennings C, Medhurst AD, Murdock P, Chapman CG. Meadows HJ, et al. Among authors: chapman cg. Pflugers Arch. 2000 Apr;439(6):714-22. doi: 10.1007/s004249900235. Pflugers Arch. 2000. PMID: 10784345

3

Cloning, localisation and functional expression of a novel human, cerebellum specific, two pore domain potassium channel.

Chapman CG, Meadows HJ, Godden RJ, Campbell DA, Duckworth M, Kelsell RE, Murdock PR, Randall AD, Rennie GI, Gloger IS. Chapman CG, et al. Brain Res Mol Brain Res. 2000 Oct 20;82(1-2):74-83. doi: 10.1016/s0169-328x(00)00183-2. Brain Res Mol Brain Res. 2000. PMID: 11042359

4

Distribution analysis of human two pore domain potassium channels in tissues of the central nervous system and periphery.

Medhurst AD, Rennie G, Chapman CG, Meadows H, Duckworth MD, Kelsell RE, Gloger II, Pangalos MN. Medhurst AD, et al. Among authors: chapman cg. Brain Res Mol Brain Res. 2001 Jan 31;86(1-2):101-14. doi: 10.1016/s0169-328x(00)00263-1. Brain Res Mol Brain Res. 2001. PMID: 11165377

5

Acute hypoxia occludes hTREK-1 modulation: re-evaluation of the potential role of tandem P domain K+ channels in central neuroprotection.

Miller P, Kemp PJ, Lewis A, Chapman CG, Meadows HJ, Peers C. Miller P, et al. Among authors: chapman cg. J Physiol. 2003 Apr 1;548(Pt 1):31-7. doi: 10.1113/jphysiol.2003.040048. Epub 2003 Feb 28. J Physiol. 2003. PMID: 12611912 Free PMC article.

6

Recombinant hTASK1 is an O(2)-sensitive K(+) channel.

Lewis A, Hartness ME, Chapman CG, Fearon IM, Meadows HJ, Peers C, Kemp PJ. Lewis A, et al. Among authors: chapman cg. Biochem Biophys Res Commun. 2001 Aug 3;285(5):1290-4. doi: 10.1006/bbrc.2001.5310. Biochem Biophys Res Commun. 2001. PMID: 11478797

7

ASP1 (BACE2) cleaves the amyloid precursor protein at the beta-secretase site.

Hussain I, Powell DJ, Howlett DR, Chapman GA, Gilmour L, Murdock PR, Tew DG, Meek TD, Chapman C, Schneider K, Ratcliffe SJ, Tattersall D, Testa TT, Southan C, Ryan DM, Simmons DL, Walsh FS, Dingwall C, Christie G. Hussain I, et al. Mol Cell Neurosci. 2000 Nov;16(5):609-19. doi: 10.1006/mcne.2000.0884. Mol Cell Neurosci. 2000. PMID: 11083922

8

Cloning, functional characterisation and population analysis of a variant form of the human glycine type 2 transporter.

Evans J, Herdon H, Cairns W, O'Brien E, Chapman C, Terrett J, Gloger I. Evans J, et al. FEBS Lett. 1999 Dec 17;463(3):301-6. doi: 10.1016/s0014-5793(99)01636-1. FEBS Lett. 1999. PMID: 10606742 Free article.

9

Identification of a novel aspartic protease (Asp 2) as beta-secretase.

Hussain I, Powell D, Howlett DR, Tew DG, Meek TD, Chapman C, Gloger IS, Murphy KE, Southan CD, Ryan DM, Smith TS, Simmons DL, Walsh FS, Dingwall C, Christie G. Hussain I, et al. Mol Cell Neurosci. 1999 Dec;14(6):419-27. doi: 10.1006/mcne.1999.0811. Mol Cell Neurosci. 1999. PMID: 10656250

10

Identifying Patients at Risk for Cardiometabolic and Chronic Diseases by Using the Exercise Vital Sign to Screen for Physical Inactivity.

Chapman CG, Schroeder MC, Marcussen B, Carr LJ. Chapman CG, et al. Prev Chronic Dis. 2025 Jan 2;22:E02. doi: 10.5888/pcd22.240149. Prev Chronic Dis. 2025. PMID: 39745943 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters